Named as a key player in 33 of our reports, across 33 regions and countries.
Our reports that name C.H. Boehringer Sohn AG & Co. as a key player, by category and place.
Markets where they are a key player. Each opens the market's statistics for every place we cover.
None of their markets match.
Our newest markets with them as a key player. Each covers 2024 history, a 2025 base year and forecasts to 2034.
Named as key players in the same markets as C.H. Boehringer Sohn AG & Co. (number of shared markets).
AstraZeneca1 shared market
Bristol-Myers Squibb1 shared market
Eli Lilly and Company1 shared market
Johnson & Johnson1 shared market
Sanofi1 shared market
The topics of the markets C.H. Boehringer Sohn AG & Co. is in.
Stories on the topics C.H. Boehringer Sohn AG & Co. works in.
Omega-3 supplements are hugely popular. Big trials give mixed answers on whether they protect the heart.
Read
Cardiovascular disease is the world's leading cause of death, and stroke caused 11.9 million new cases in…
Read
2.4 billion people live with a condition that could benefit from rehabilitation. The need rose 63% since 1990.
ReadSearch all reports for C.H. Boehringer Sohn AG & Co. All companies